What's New
6.11.09
"New Study Demonstrates NanoScan`s Novel Contrast Agent May Identify Heart Attack in Waiting" company press release
"New Study Demonstrates NanoScan`s Novel Contrast Agent May Identify Heart Attack in Waiting" company press release
The following select articles, abstracts and presentations are available by clicking on the highlighted story title:
August 2009 - "Multi-slice computed tomography with N1177 identifies ruptured atherosclerotic plaques in rabbits" in Basic Res Cardiol. 2009 Aug 20. Van Herck JL, De Meyer GR, Martinet W, Salgado RA, Shivalkar B, De Mondt R, Van De Ven H, Ludwig A, Van Der Veken P, Van Vaeck L, Bult H, Herman AG, Vrints CJ.
June 2009 - "Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology" in J Nucl Med. 2009 Jun;50(6):959-65. Epub 2009 May 14. Hyafil F, Cornily JC, Rudd JH, Machac J, Feldman LJ, Fayad ZA.
May 2007 - "Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography" in Nat Med. 2007 May;13(5):636-41. Epub 2007 Apr 8. Hyafil F, Cornily JC, Feig JE, Gordon R, Vucic E, Amirbekian V, Fisher EA, Fuster V, Feldman LJ, Fayad ZA.
NanoScan Imaging, LLC
2250 Berks Road
Lansdale, PA 19446
P: 610-647-3231
info@nanoscanimaging.com
www.nanoscanimaging.com